SEC Comment Letter for BIO-TECHNE Corp (TECH) (CIK 0000842023) (TECH) — Apr 16, 2021
BIO-TECHNE Corp (TECH) (CIK 0000842023)
Date: April 16, 2021 · CIK: 0000842023 · Accession: 0000000000-21-004772
AI Filing Summary & Sentiment
File numbers found in text: 000-17272
Letter
United States securities and exchange commission logo April 16, 2021 James Hippel Chief Financial Officer Bio-Techne Corporation 614 McKinley Place N.E. Minneapolis, MN 55413 Re:Bio-Techne Corporation Form 10-K for the Fiscal Year Ended June 30, 2020 Filed August 26, 2020 File No. 000-17272 Dear Mr. Hippel: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
April 16, 2021
James Hippel
Chief Financial Officer
Bio-Techne Corporation
614 McKinley Place N.E.
Minneapolis, MN 55413
Re:Bio-Techne Corporation
Form 10-K for the Fiscal Year Ended June 30, 2020
Filed August 26, 2020
File No. 000-17272
Dear Mr. Hippel:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences